JITC

Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214
Charlene M Mantia, Opeyemi A Jegede, Elizabeth R Plimack, Thomas Powles, Robert J Motzer, Nizar M Tannir, Chung-Han Lee, Yoshihiko Tomita, Martin H Voss, Toni K Choueiri, Brian I Rini, Hans J Hammers, Bernard Escudier, Laurence Albigès, Lisa Rosenblatt, Michael B Atkins, Meredith M Regan, David F McDermott

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e009495; DOI: 10.1136/jitc-2024-009495
Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signalling
Edward Armstrong, Matthew K L Chiu, Shane Foo, Lizzie Appleton, Pablo Nenclares, Anton Patrikeev, Nitya Mohan, Martin Mclaughlin, Galabina Bozhanova, Julia Hoebart, Victoria Roulstone, Emmanuel Patin, Malin Pedersen, Joan Kyula, Masahiro Ono, Fiona Errington-Mais, John Bell, Kevin J Harrington, Alan Melcher, Victoria Jennings

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e009443; DOI: 10.1136/jitc-2024-009443
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells
Anders W Matson, Rob Hullsiek, Kate J Dixon, Sam Wang, Anders J Lindstedt, Ryan R Friess, Shee Kwan Phung, Tanya S Freedman, Martin Felices, Emily N Truckenbrod, Jianming Wu, Jeffrey S Miller, Bruce Walcheck

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e008959; DOI: 10.1136/jitc-2024-008959
Immune cell topography of head and neck cancer
Tara Muijlwijk, Dennis N L M Nijenhuis, Sonja H Ganzevles, Fatima Ekhlas, Carmen Ballesteros-Merino, Laura A N Peferoen, Elisabeth Bloemena, Bernard A Fox, Jos B Poell, C René Leemans, Ruud H Brakenhoff, Rieneke van de Ven

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e009550; DOI: 10.1136/jitc-2024-009550
Phase I study of the safety and clinical activity of the interleukin-8 inhibitor AMY109 combined with atezolizumab in patients with advanced solid cancers
Noboru Yamamoto, Shigehisa Kitano, Takafumi Koyama, Masafumi Ikeda, Hidenori Mizugaki, Takatsugu Narikiyo, Yuki Yamaguchi, Takaaki Ishida, Ryoko Takubo, Chika Ogami, Mayuko Sekiya, Yuki Nakagawa, Yasutoshi Kuboki

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e009262; DOI: 10.1136/jitc-2024-009262
Merkel cell carcinoma refractory to anti-PD(L)1: utility of adding ipilimumab for salvage therapy
Tomoko Akaike, Austin J Jabbour, Peter H Goff, Song Y Park, Shailender Bhatia, Paul Nghiem

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e009396; DOI: 10.1136/jitc-2024-009396
Impact of LAG-3/FGL1 pathway on immune evasive contexture and clinical outcomes in advanced urothelial carcinoma
Takashi Yoshida, Takahiro Nakamoto, Naho Atsumi, Chisato Ohe, Takeshi Sano, Yoshiki Yasukochi, Koji Tsuta, Hidefumi Kinoshita

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e009358; DOI: 10.1136/jitc-2024-009358
Peptide-based PET tracer targeting LAG-3 for evaluating the efficacy of immunotherapy in melanoma
Peizhe Yuan, Yu Long, Nannan Wei, Yan Wang, Ziyang Zhu, Jinquan Han, Dawei Jiang, Xiaoli Lan, Yongkang Gai

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e009010; DOI: 10.1136/jitc-2024-009010
rhIL-7-hyFc, a long-acting interleukin-7, improves efficacy of CAR-T cell therapy in solid tumors
Dan Li, Tianyuzhou Liang, Laura E Hutchins, Alexandra A Wolfarth, Sara Ferrando-Martinez, Byung Ha Lee, Mitchell Ho

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e008989; DOI: 10.1136/jitc-2024-008989
Directing B7-H3 chimeric antigen receptor T cell homing through IL-8 induces potent antitumor activity against pediatric sarcoma
Jessica A Lake, Elena Woods, Eric Hoffmeyer, Kristin L Schaller, Joselyn Cruz-Cruz, Joseph Fernandez, Dejene Tufa, Benjamin Kooiman, Spencer C Hall, Dallas Jones, Masanori Hayashi, Michael R Verneris

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e009221; DOI: 10.1136/jitc-2024-009221

Main menu

JITC

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

JITC

Pages